Lacktman Comments on Confusion Over DEA’s Telemedicine Rulemaking

Partner Nate Lacktman was quoted in a Politico article, “HHS extends interoperability comment window,” about lingering confusion over an expected Drug Enforcement Administration rule that is supposed to clarify when doctors can register to prescribe controlled substances via telemedicine.

Lacktman said it is not clear what will be in the rule, which is expected to come out in October. If the rule isn’t specific enough or if it restricts prescribing to certain specialties or substances, clinicians might not feel comfortable prescribing virtually, he said.